UD signs commercialization agreement on corn disease trait
The University of Delaware announced that it has reached a commercial agreement with DuPont regarding their multi-year, corn disease resistance research collaboration. Terms of the agreement were not disclosed.
DuPont seed business, Pioneer Hi-Bred, now is marketing Pioneer brand hybrid 34F26, the first corn hybrid in North America to carry the trait, which provides enhanced resistance to anthracnose stalk rot. Additional hybrids carrying the trait are being evaluated for 2010.
James A. Hawk, UD professor of plant and soil sciences, became familiar in the 1980s with a gene in corn known to provide resistance to the fungus Colletotrichum graminicola, which causes the often devastating disease anthracnose stalk rot (ASR). At the time the gene was found only in a "tropical" corn line from Mississippi, which could not be used commercially.
Hawk worked for more than 20 years to demonstrate that the gene could be bred into commercial germplasm and developed "near-isogenic lines" that facilitated the genetic characterization of ASR resistance. He and his associates then teamed up with DuPont scientists and cutting-edge technology was used to "fine map" the gene and develop molecular markers under a Collaborative Research Agreement between DuPont and the University. DuPont scientists are using those markers in high throughput genetic technology to move the gene into a wide variety of elite commercial germplasm. Intellectual property protection is pending on the discoveries of the collaboration and the corn lines developed by Hawk.
The increased incidence of anthracnose stalk rot is thought to be associated with increased use of no-till agricultural practices that are utilized to reduce soil erosion and fuel costs. Higher risk of the disease also is associated with corn planted in fields that had corn the previous year because the pathogen over-winters in corn residue. Yield losses due to the disease, estimated to be about $1billion annually in North America are the result of reduced ear size, premature plant death and stalk breakage of the plant below the ear, all of which decrease harvestable yield.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Snake venom could make surgery safer for patients on blood thinners
ORCA Therapeutics licenses oncolytic adenovirus technology from VCN Biosciences
Bentley Pharmaceuticals and the University of New Hampshire Announce Advances in Nanotechnology Research Program

Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million - "This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future"
Walter Reed Army Institute and Siam Life Science Develop New Gold Standard for Pharmacological and Toxicological Test Systems - Siam Life Science Secures Exclusive License For Unique Liver Cell Line From Walter Reed Army Institute Of Research
Artificial 'plants' could fuel the future
Novasep Appoints a New Chairman for its Supervisory Board - Bernard Dubois, Former Aventis Senior VP of Global Industrial Operations Brings a Wealth of Experience to Novasep's Top Management Team
